收费全文 | 23462篇 |
免费 | 1685篇 |
国内免费 | 35篇 |
耳鼻咽喉 | 306篇 |
儿科学 | 751篇 |
妇产科学 | 498篇 |
基础医学 | 3107篇 |
口腔科学 | 453篇 |
临床医学 | 2773篇 |
内科学 | 4804篇 |
皮肤病学 | 351篇 |
神经病学 | 2481篇 |
特种医学 | 818篇 |
外国民族医学 | 3篇 |
外科学 | 2709篇 |
综合类 | 265篇 |
一般理论 | 14篇 |
预防医学 | 2533篇 |
眼科学 | 493篇 |
药学 | 1493篇 |
中国医学 | 31篇 |
肿瘤学 | 1299篇 |
2023年 | 127篇 |
2022年 | 185篇 |
2021年 | 492篇 |
2020年 | 272篇 |
2019年 | 462篇 |
2018年 | 510篇 |
2017年 | 406篇 |
2016年 | 446篇 |
2015年 | 488篇 |
2014年 | 698篇 |
2013年 | 1016篇 |
2012年 | 1578篇 |
2011年 | 1627篇 |
2010年 | 848篇 |
2009年 | 822篇 |
2008年 | 1364篇 |
2007年 | 1374篇 |
2006年 | 1364篇 |
2005年 | 1361篇 |
2004年 | 1282篇 |
2003年 | 1179篇 |
2002年 | 1078篇 |
2001年 | 434篇 |
2000年 | 403篇 |
1999年 | 366篇 |
1998年 | 242篇 |
1997年 | 195篇 |
1996年 | 194篇 |
1995年 | 159篇 |
1994年 | 155篇 |
1993年 | 148篇 |
1992年 | 233篇 |
1991年 | 257篇 |
1990年 | 247篇 |
1989年 | 221篇 |
1988年 | 198篇 |
1987年 | 229篇 |
1986年 | 216篇 |
1985年 | 244篇 |
1984年 | 177篇 |
1983年 | 155篇 |
1982年 | 99篇 |
1981年 | 118篇 |
1980年 | 110篇 |
1979年 | 145篇 |
1978年 | 102篇 |
1977年 | 88篇 |
1976年 | 83篇 |
1975年 | 96篇 |
1974年 | 90篇 |
Objectives
Short successive periods of skeletal muscle disuse have been suggested to substantially contribute to the observed loss of skeletal muscle mass over the life span. Hospitalization of older individuals due to acute illness, injury, or major surgery generally results in a mean hospital stay of 5 to 7 days, during which the level of physical activity is strongly reduced. We hypothesized that hospitalization following elective total hip arthroplasty is accompanied by substantial leg muscle atrophy in older men and women.Design and participants
Twenty-six older patients (75 ± 1 years) undergoing elective total hip arthroplasty participated in this observational study.Measurements
On hospital admission and on the day of discharge, computed tomographic (CT) scans were performed to assess muscle cross-sectional area (CSA) of both legs. During surgery and on the day of hospital discharge, a skeletal muscle biopsy was taken from the m. vastus lateralis of the operated leg to assess muscle fiber type–specific CSA.Results
An average of 5.6 ± 0.3 days of hospitalization resulted in a significant decline in quadriceps (?3.4% ± 1.0%) and thigh muscle CSA (?4.2% ± 1.1%) in the nonoperated leg (P < .05). Edema resulted in a 10.3% ± 1.7% increase in leg CSA in the operated leg (P < .05). At hospital admission, muscle fiber CSA was smaller in the type II vs type I fibers (3326 ± 253 μm2 vs 4075 ± 279 μm2, respectively; P < .05). During hospitalization, type I and II muscle fiber CSA tended to increase, likely due to edema in the operated leg (P = .10).Conclusions
Six days of hospitalization following elective total hip arthroplasty leads to substantial leg muscle atrophy in older patients. Effective intervention strategies are warranted to prevent the loss of muscle mass induced by short periods of muscle disuse during hospitalization. 相似文献Methods: A retrospective cohort design and data from two US healthcare claims repositories were employed. The study population included patients who had non-metastatic cancer of the breast, colon/rectum, lung or ovaries, or non-Hodgkin’s lymphoma (NHL), and who received myelosuppressive chemotherapy regimens with an intermediate/high risk for FN. For each patient, the first cycle of the first course was characterized in terms of PP-CSF use and FN episodes. Crude incidence proportions for PP-CSF and FN during the first cycle were estimated by calendar quarter (2010–2016); multivariable logistic regression models were used to estimate quarter-specific adjusted mean probabilities of FN by PP-CSF use.
Results: The study population totaled 142,730 patients with breast cancer (61%), colorectal cancer (14%), NHL (11%), ovarian cancer (10%) or lung cancer (5%). PP-CSF use increased from 52% in 1Q2010 to 58% in 4Q2016; pegfilgrastim was the most commonly used agent (>96% across quarters). PP-CSF administration on the same day as chemotherapy ranged from 8 to 11% until 1Q2015, and increased to 64% by 4Q2016. Adjusted incidence proportions for FN in the first chemotherapy cycle ranged from 2.7% (95% CI: 2.3–3.0) to 3.7% (95% CI: 3.1–4.3) among those who did not receive PP-CSF, and was 2.6% (95% CI: 2.5–2.7) across quarters among those who received PP-CSF.
Conclusions: Although the use of PP-CSF is commonplace in current US clinical practice, underutilization in cancer patients receiving chemotherapy regimens with an intermediate/high risk for FN may still be an issue. Use of same-day PP-CSF increased markedly from the end of 2015, although this finding reflects (at least in part) increased uptake of pegfilgrastim delivered via an on-body injector as well as the recent change in clinical practice guidelines. Overall, patients receiving PP-CSF appear to have a lower risk of FN during the first cycle of chemotherapy. 相似文献